These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28276287)

  • 1. Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles.
    Cichero E; Tonelli M; Novelli F; Tasso B; Delogu I; Loddo R; Bruno O; Fossa P
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):375-402. PubMed ID: 28276287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents.
    Tonelli M; Novelli F; Tasso B; Vazzana I; Sparatore A; Boido V; Sparatore F; La Colla P; Sanna G; Giliberti G; Busonera B; Farci P; Ibba C; Loddo R
    Bioorg Med Chem; 2014 Sep; 22(17):4893-909. PubMed ID: 25082514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.
    Francesconi V; Cichero E; Schenone S; Naesens L; Tonelli M
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32218301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral assays of some 2-substituted benzimidazole-N-carbamates.
    Garuti L; Roberti M; Gentilomi G
    Farmaco; 2000 Jan; 55(1):35-9. PubMed ID: 10755229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity.
    Wang XA; Cianci CW; Yu KL; Combrink KD; Thuring JW; Zhang Y; Civiello RL; Kadow KF; Roach J; Li Z; Langley DR; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4592-8. PubMed ID: 17576060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing the binding mode between respiratory syncytial virus fusion protein and benzimidazole-based inhibitors.
    Ji D; Ye W; Chen H
    Mol Biosyst; 2015 Jul; 11(7):1857-66. PubMed ID: 25872614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo.
    Yu KL; Wang XA; Civiello RL; Trehan AK; Pearce BC; Yin Z; Combrink KD; Gulgeze HB; Zhang Y; Kadow KF; Cianci CW; Clarke J; Genovesi EV; Medina I; Lamb L; Wyde PR; Krystal M; Meanwell NA
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1115-22. PubMed ID: 16368233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, in vitro and in vivo anti-respiratory syncytial virus (RSV) activity of novel oxizine fused benzimidazole derivatives.
    Huo X; Hou D; Wang H; He B; Fang J; Meng Y; Liu L; Wei Z; Wang Z; Liu FW
    Eur J Med Chem; 2021 Nov; 224():113684. PubMed ID: 34256126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel benzimidazo[2,1-c][1,4]thiazinone derivatives with potent activity against HSV-1.
    Galal SA; El-Naem SI; El-Nezhawy AO; Ali MA; El-Diwani HI
    Arch Pharm (Weinheim); 2011 Apr; 344(4):255-63. PubMed ID: 21469175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
    Xue F; Luo X; Ye C; Ye W; Wang Y
    Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus.
    Andries K; Moeremans M; Gevers T; Willebrords R; Sommen C; Lacrampe J; Janssens F; Wyde PR
    Antiviral Res; 2003 Nov; 60(3):209-19. PubMed ID: 14638397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.
    Tonelli M; Naesens L; Gazzarrini S; Santucci M; Cichero E; Tasso B; Moroni A; Costi MP; Loddo R
    Eur J Med Chem; 2017 Jul; 135():467-478. PubMed ID: 28477572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of norakin on respiratory syncytial virus in tissue culture and in mice.
    Mentel R; Schroeder C; Döhner L
    Acta Virol; 1989 Mar; 33(2):162-6. PubMed ID: 2569812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-benzimidazole containing inhibitors of respiratory syncytial virus.
    Pryde DC; Tran TD; Gardner I; Bright H; Stupple P; Galan S; Alsop L; Watson L; Middleton DS; Dayal S; Platts M; Murray EJ; Parkinson T; Webster R
    Bioorg Med Chem Lett; 2013 Feb; 23(3):827-33. PubMed ID: 23265891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.
    Sudo K; Miyazaki Y; Kojima N; Kobayashi M; Suzuki H; Shintani M; Shimizu Y
    Antiviral Res; 2005 Feb; 65(2):125-31. PubMed ID: 15708639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
    Cheng J; Xie J; Luo X
    Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents.
    Wang M; Zhang G; Zhao J; Cheng N; Wang Y; Fu Y; Zheng Y; Wang J; Zhu M; Cen S; He J; Wang Y
    Eur J Med Chem; 2021 Mar; 214():113208. PubMed ID: 33571829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 capsid assembly: optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold.
    Tremblay M; Bonneau P; Bousquet Y; DeRoy P; Duan J; Duplessis M; Gagnon A; Garneau M; Goudreau N; Guse I; Hucke O; Kawai SH; Lemke CT; Mason SW; Simoneau B; Surprenant S; Titolo S; Yoakim C
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7512-7. PubMed ID: 23122820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater
    Zhao M; Zheng ZZ; Chen M; Modjarrad K; Zhang W; Zhan LT; Cao JL; Sun YP; McLellan JS; Graham BS; Xia NS
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of some benzimidazole derivatives with trichomonicidal activity.
    Pérez-Villanueva J; Medina-Franco JL; Caulfield TR; Hernández-Campos A; Hernández-Luis F; Yépez-Mulia L; Castillo R
    Eur J Med Chem; 2011 Aug; 46(8):3499-508. PubMed ID: 21621311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.